Form D · Biotechnology

Rocket Pharmaceuticals Ltd.

Grand Cayman, E9 · CIK 0001663128

Offering snapshot reported May 5, 2017 · SEC filing

Reported sold
$25.1M
Offering amount: $30.1M
Investors reported
15
Form D · investor count
Minimum accepted
$24K
Reported outside-investor minimum
First sale
Feb 14, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$12.6M$25.1MMar 2, 2017: $12,024,787.00Mar 2, 2017May 5, 2017: $25,137,888.00May 5, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$12,024,787 → $25,137,888
  • Reported investors11 → 15

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 5, 2017Amendment$25,137,888$13,113,101vs Mar 2, 201715SEC filing
Mar 2, 2017Initial$12,024,787No comparison11SEC filing
Jan 15, 2016Initial$16,425,000No comparison16SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-281598

Source: Form D, filed May 5, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gaurav Shah Executive
Roderick Wong Director
Naveen Yalamanchi Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
Co Services Cayman Limited, Po Box 10008 Willow House, Cricket Square
Grand Cayman, E9, KY1-1001